ER+ Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference
HTML-код
- Опубликовано: 11 сен 2024
- For Total Health's 2022 Best of Breast Conference, we bring you a case panel discussion focused on ER+ breast cancer.
Our expert panelists include Dr. Reshma Mahtani from Miami Cancer Institute; Dr. Ting Bao from Memorial Sloan Kettering Cancer Center; Dr. Terry Mamounas from Orlando Health Cancer Institute; and Dr. Hatem Soliman from Moffitt Cancer Center.
To obtain credit for this CME activity you must watch the full 2022 Best of Breast Conference Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.
Recurrence is because they never restore proper ERb1 signaling to counter act ER alpha .... shame what's going on... Hormone imbalances are ignored.
My gf has stage 2a breast cancer, Er+/HER-2 negative, with three positive lymph nodes with high percentages of estrogen and progesterone. She is 37, has oncotype score of 6, distant reoccurrence score at 11%, with no apparent benefit with chemo. Her ki67 is 7% and her blood work is 19 U/mL. She is planning on doing ovarian suppression. She is grade 2. She had nipple reserving double mastectomy. She’s very healthy. Her mother and grandmother had breast cancer. I know chemo suppresses ovaries (and helps by 5%), but she doesn’t want it. Would adjuvant endocrine therapy be recommended on these results?
Thanks you so much Dr Obulor for your ultimate help in curing my cancer permanently, although the word wouldn't believe in herbs. I will because you have shown me the power of these herbs, i sincerely appreciate you Dr 💛